Rheumatology Flashcards
Which joints are never/rarely involved in RA?
- Lumbar spine
2. DIPJ
10 extra articular features of RA
- Skin - raynauds phenomenon, leg ulcers
- Eyes - scleritis, sjogrens syndrome, cataracts secondary to steroids
- Cricoarytenoid joint disease (sore throat, hoarse voice, neck pain), recurrent headaches at the base of the skull or arm tingling from C1-2 subluxation
- Lungs - ILD, pleural effusion, pleuritis
- Heart - pericarditis, valve disease due to rheuamtoid nodules, ACS
- Renal - drug use, amyloid (all rare)
- Nervous system - peripheral neuropathy, entrapment neuropathy, mononeuritis multiplex
- Blood - ACD, felty’s syndrome
- Systemic - fevers, weight loss, fatigue
- vasculitis - digital arteritis, ulcers, pyoderma gangrenosum
4 side effects of MTX
- Hepatic toxicity
- Pulmonary fibrosis
- Thrombocytopenia
- Leukopenia
3 side effects of leflunomide
- Diarrhoea
- Alopecia
- Liver toxicity
3 side effects of HCQ
- Nausea
- Pigmentation
- Retinopathy - needs regular ophthalmological review
5 side effects of sulfasalazine
- Rash
- Nausea
- Haematological abnormalities
- LFT derangements
- Reversible oligospermia
5 differential diagnosis of deforming, symmetrical, chronic polyarthropathy
- Rheumatoid arthritis
- Psoriatic arthropathy or other seronegative arthropathies
- Chronic tophaceous gout (rarely symmetrical)
- Primary generalized osteoarthritis
- SLE - usually but not always non-deforming
4 causes of arthritis and nodules
- SEROPOSITIVE RA
- SLE - rare
- Rheumatic fever - very rarely
- Amyloid arthropathy in conjunction with myeloma
4 criteria for diagnosis of RA according to 2010 ACR/EULAR RA criteria
- Number of joints involved
- Serology (RF, ACPA)
- Acute phase reactant (CRP, ESR)
- Duration of symptoms - <6 weeks or >6 weeks
Anti-CCP antibodies
More specific at 97%
Associated with more severe disease course and erosive disease
Rheumatoid factor
70% of patients are seropositive
Positive especially if they have rheumatoid nodules or associated vasculitis
Xray changes to look for in RA
- Soft tissue swelling
- Symmetrical joint space narrowing - in OA the narrowing are asymmetrical
- Juxtaarticular osteoporosis
- Marginal joint erosions
Action of leflunomide
Pyrimidine antagonist which inhibits the proliferation of T cells
2 major poor prognostic markers in RA
Large number of joints involved at the outset
Significant abnormalities in the inflammatory markers
Causes of drug induced SLE
- Procainamide
- Hydralazine
- Isoniazid
- Methyldopa
- Penicillamine
For both procainamide and hydralazine, most patients are ANA positive within 1 year.
5 clinical features of GPA
- Nasal congestion
- Rhinorrhoea
- Bloody ansal discahrge
- Cough with haemoptysis
- Breathlessness
Disease association with polyarteritis nodosa
Hepatitis B - 1/3 of cases
5 clinical features of EGPA
- Asthma
- Allergic rhinitis, nasal polyps, saddle nose
- Eczema
- Cough and breathlessness
- PNS disease such as symemtrical peripheral neuropathy or mononeuritis multiplex
Asthma occurs before peripheral eosinophilia
4 features of mixed essential cryoglobulinaemia
- Palpable purpura of the extremities
- Raynauds disease
- Arthritis
- Neuropathy
Concurrent Hep C is common
Differential diagnosis of livedo reticularis
- ANCA vasculitis
- Cholesterol atheroembolism after vascular procedure
- APLS
5 year survival rate for scleroderma
70%
Which patient group have higher incidence of diffuse disease and of ILD?
Asian patients
Manifestations of scleroderma:
Dermatological: Arthritis: GI: Renal: Respiratory: Cardiac: Others:
Dermatological: Raynauds (commonly the first symptom), tight skin, sclerodactyly
Arthritis: arthropathy in rheumatoid distribution, carpal tunnel syndrome
GI: dysphagia, heart burn (oesophagitis), diarrhoea causing malabsorption
Renal: HTN, CKD
Respiratory: ILD, pleurisy, PTHN
Cardiac: Pericarditis, arrhythmias, dilated cardiomyopathy
Others: Erectile dysfunction, hypothyroidism, non-melanoma skin cancers
Differential diagnosis to manifestations of scleroderma
- Eosinophilic fasciitis
- Diabetic cheiroarthropathy
- Nephrogenic systemic fibrosis